Allurion Technologies, Inc. has received a delisting notice from the NYSE due to non-compliance with market capitalization requirements. The company is appealing this decision while its stock trades on the OTCID Market. Recent FDA approval may aid compliance efforts.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.